Treatment of Primary Dysmenorrhea with Acupuncture: An Alternative to Medications
Keywords:
Acupressure, Primary Dysmenorrhea, Menstrual Pain, Non-Pharmacological InterventionAbstract
Among the many gynecological disorders that can afflict young women and girls, primary dysmenorrhea ranks high. Period cramps that are both unpleasant and non-pathological are the hallmark of this condition. Everyday life, productivity at work, academic achievement, and quality of life can all be severely affected by the illness. Despite the widespread use of pharmacological treatments like oral contraceptives and nonsteroidal anti-inflammatory medicines (NSAIDs), there has been a rise in interest in non-pharmacological techniques like acupressure due to concerns about side effects and long-term pharmaceutical use. According to the research that were examined, acupressure can help women with primary dysmenorrhea greatly decrease the severity and length of their menstrual pain. Acupressure patients reported less discomfort, less need for analgesics, and better capacity to carry out daily tasks after treatment. Additionally, a number of studies found that it helped with related symptoms including nausea, exhaustion, headache, and mental distress. In most cases, acupressure was determined to be risk-free, cheap, simple to use, and accompanied by little negative side effects. There is mounting evidence that acupressure can effectively and safely manage primary dysmenorrhea without the use of pharmaceuticals. Women looking for alternatives to medication-based therapies can benefit from its capacity to decrease menstruation discomfort and enhance general well-being. In order to bolster the evidence base and back up clinical recommendations, greater sample sizes and standardized intervention techniques are necessary for additional high-quality randomized controlled studies.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 The Sankalpa: International Journal of Management Decisions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.